Interestingly, DOC2B levels are reduced in T2D human skeletal muscle (132), suggesting that DOC2B loss could be important for diabetogenesis and implicating DOC2B as a candidate therapeutic target for prediabetes and T2D. The gene discussed is DOC2B; the disease is prediabetes syndrome.